| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 23, 2025Virtual Press Office and PR Newswire: General Trade show news
Novel Diabetes Gene Therapy Shows Potential for Re-Dosing Using Non-Viral Delivery System AUSTIN, Texas, June 23, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a...
-
Jun 23, 2025Virtual Press Office and PR Newswire: General Trade show news
Versatile smart label combines thinnest form factor, peel-and-stick design and patent-pending activation to facilitate flexible, fast placement and easy operation Seamless integration with...
-
Jun 23, 2025Virtual Press Office and PR Newswire: General Trade show news
The 137th China Import and Export Fair (Canton Fair) wrapped up in a flurry of excitement, breaking records for international buyer attendance again. Among the bustling crowds was Coop Far East,...
-
Jun 23, 2025Virtual Press Office and PR Newswire: General Trade show news
Developed to address EGFR inhibitor-induced skin toxicities in cancer patients NEW YORK, June 23, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical...
-
Jun 23, 2025Virtual Press Office and PR Newswire: General Trade show news
Omada A/S ("Omada"), a global leader of Identity Governance and Administration (IGA), today announced a renewed strategic focus on its long-standing partnership with iC Consult, the leading...
-
Jun 23, 2025Virtual Press Office and PR Newswire: General Trade show news
New Cordial Edge™ AI feature intelligently segments customers by price responsiveness for more precise discounting, better engagement and greater profitability. SAN DIEGO, June 23, 2025...
-
Jun 22, 2025Virtual Press Office and PR Newswire: General Trade show news
Findings Highlight Potential for Novel Approach to Insulin Delivery in Pediatric Population CHICAGO, June 22, 2025 /PRNewswire/ -- Today, a new study demonstrates inhaled insulin as a safe and...
-
Jun 21, 2025Virtual Press Office and PR Newswire: General Trade show news
The investigational once-daily pill lowered A1C by an average of 1.3% to 1.6% across doses, with improvements seen as early as four weeks, in adults with type 2 diabetes In ACHIEVE-1, orforglipron...
-
Jun 20, 2025Virtual Press Office and PR Newswire: General Trade show news
Findings from 16-week trial of novel compression patch will be shared for the first time at the 85th Scientific Sessions of the American Diabetes Association, beginning today FREMONT, Calif., June...
-
Jun 20, 2025Virtual Press Office and PR Newswire: General Trade show news
New Research Demonstrates Significant Benefits of Simple Dietary Switch for Blood Glucose Control and Long-Term Weight Management CHICAGO, June 20, 2025 /PRNewswire/ -- Consistently replacing diet...
